G1 Believes Boehringer Is Better Bet To Sell Trilaciclib

Drops Plans To Market Alone In US

 
• By Kevin Grogan
  
Hikers
Boehringer gives G1 a helping commercial hand • Source: Shutterstock

More from Anticancer

More from Therapy Areas